jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Nov. 12, 2024

Nov. 12, 2024

jRCT1051240182

Research on chronic pain treatment with human-derived mesenchymal stem cell conditioned medium

Research on chronic pain treatment with MSC-CM

Takome Shoka

Seishin Medical Clinic

Collect Mark Meieki 4-chome 6F, 4-11-1 Meieki Nakamura-ku, Nagoya-shi, Aichi 450-0002

+81-52-462-9838

seishinmedicalclinic@gmail.com

Takome Shoka

Seishin Medical Clinic

Collect Mark Meieki 4-chome 6F, 4-11-1 Meieki Nakamura-ku, Nagoya-shi, Aichi 450-0002

+81-52-462-9838

seishinmedicalclinic@gmail.com

Recruiting

April. 24, 2024

Observational

1. Individuals who did not experience satisfactory pain relief effects with standard therapy.
2. Individuals who do not wish to undergo treatment with drugs commonly used in standard therapy due to concerns about side effects, and whose physicians have determined that treatment with conditioned medium is appropriate for chronic pain relief.
<Eligibility Criteria>
Patients meeting the following criteria are eligible:
1. Individuals aged 18 years or older.
2. Individuals with normal capacity to consent.
3. Individuals who have been provided with the informed consent document for this treatment, have received sufficient explanation, and are capable of providing written consent freely and voluntarily.
4. Individuals for whom the attending physician has recognized the necessity of treatment.

<Exclusion Criteria>
Individuals meeting any of the following conditions will be excluded:
1. Users of narcotics or stimulants.
2. Individuals deemed inappropriate by the attending physician.

18age old over
No limit

Both

chronic pain

Arthritis pain, Back pain, Persistent pain, Neuropathic pain, Musculoskeletal pain

D009132

Assessment of pain (ache) in terms of subjective symptoms of the research participants, evaluating the following items:
1) Impact of pain on daily life
2) Pattern of pain
3) Intensity of pain (Numerical Rating Scale; NRS)
4) Location of pain
5) Nature of pain

Seishin Medical Clinic
Safety Assessment and Clinical Research in Japan
13-16 Sanjo Minamicho, Ashiya City, Hyogo

+81-797-22-5511

jpgh@ace.odn.ne.jp
Approval

April. 24, 2024

No

none